Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The consensus 5' splice site motif inhibits mRNA nuclear export.
Lee ES, Akef A, Mahadevan K, Palazzo AF. Lee ES, et al. Among authors: mahadevan k. PLoS One. 2015 Mar 31;10(3):e0122743. doi: 10.1371/journal.pone.0122743. eCollection 2015. PLoS One. 2015. PMID: 25826302 Free PMC article.
RanBP2/Nup358 enhances miRNA activity by sumoylating Argonautes.
Shen Q, Wang YE, Truong M, Mahadevan K, Wu JJ, Zhang H, Li J, Smith HW, Smibert CA, Palazzo AF. Shen Q, et al. Among authors: mahadevan k. PLoS Genet. 2021 Feb 18;17(2):e1009378. doi: 10.1371/journal.pgen.1009378. eCollection 2021 Feb. PLoS Genet. 2021. PMID: 33600493 Free PMC article.
Follmann balanitis - A very rare presentation of primary syphilis.
Arunprasath P, Someshwaran R, Mahadevan K, Babu NP, Ashwathi S. Arunprasath P, et al. Among authors: mahadevan k. Indian J Sex Transm Dis AIDS. 2023 Jul-Dec;44(2):163-164. doi: 10.4103/ijstd.ijstd_76_22. Epub 2023 Dec 6. Indian J Sex Transm Dis AIDS. 2023. PMID: 38223147 Free PMC article.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
106 results